The U.S. Food & Drug Administration ("FDA") announced in an early morning press release on November 7, 2017, that it is withdrawing the draft Guidance for Industry #230, "Compounding Animal Drugs from Bulk Drug Substances."

On September 26, 2017, FDA Commissioner Scott Gottlieb, M.D. released a statement about FDA's ramped up regulatory initiatives for drug compounders.